Chordin, Chordin-like 1, and Chordin-like 2 are secreted bone morphogenetic protein (BMP) antagonists with highly conserved Chordin-like cysteine-rich domains. Recently, Brorin and Brorin-like have been identified as new Chordinlike BMP antagonists. A Chordin ortholog, Short gastrulation, has been identified in Drosophila, a protostome, but not other orthologs. By contrast, Chordin, Chordin-like 1, and Chordin-like 2 have been identified in Ciona intestinalis, the closest living relatives of the vertebrates, but Brorin and Brorin-like have not. However, all these genes have been identified in most vertebrates. These results indicate that Chordin, Chordin-like 1, and Chordin-like 2 were generated early in the metazoan lineage. Later on, Brorin and Brorin-like were potentially generated by a genome duplication event in early vertebrate evolution. All four cysteine-rich domains of Chordin are essential for the regulation of its action. However, Chordin-like 1, Chordin-like 2, Brorin, and Brorin-like contain only two or three cysteine-rich domains. Although their mechanisms of action remain unclear, they might be distinct from that of Chordin. The expression profiles of these genes in mice and zebrafish indicate unique roles at embryonic and postnatal stages. Mutant/knockdown mouse and zebrafish phenotypes indicate roles in morphogenesis during gastrulation, dorsoventral axis formation, ear, pharyngeal, and neural development, and venous and arterial patterning. Aberrant Chordin expression might result in hereditary diseases and cancer. In addition, altered serum Chordin and Chordin-like 1 levels are also observed in non-hereditary diseases. Together, these results indicate pathophysiological roles.
Introduction
Bone morphogenetic proteins (BMPs) are secreted growth factors or cytokines that belong to the transforming growth Both authors contributed equally to this work. a factor b (TGFb) superfamily. Originally identified in the protein extracts of deminerized bone, BMPs promote endochondral bone formation. However, they also play diverse roles in developmental and metabolic processes at the embryonic and postnatal stages. BMPs are secreted as dimers and activate specific Ser/Thr kinase receptors at cell surfaces. The activated receptors propagate BMP signals via the phosphorylation of Smad proteins and other non-canonical intracellular effectors (1, 2) .
The actions of BMPs are inhibited by several secreted BMP antagonists. Most extracellular BMP antagonists inhibit BMPs by binding to them. The amino acid sequences of secreted BMP antagonists are characterized by cysteine-rich (CR) domains. On the basis of the spacing of cysteine residues in the CR domains, secreted BMP antagonists can be classified into five groups; the Dan family, Twisted gastrulation (Twsg1), Follistatin, Noggin, and Chordin (2) (3) (4) (5) . However, Twsg1 either inhibits or enhances BMP signaling in different cellular contexts (6) . Chordin was originally identified as a novel dorsalizing factor in Xenopus. Chordin is a secreted BMP antagonist with highly conserved CR domains (3, 7, 8) . Chordin-like 1 (Chrdl1) and Chordin-like 2 (Chrdl2) were also identified as secreted BMP antagonists with Chordin-like CR domains (9, 10) . Recently, Brorin and Brorin-like have been identified also (11, 12) . These BMP antagonists with Chordin-like CR domains have been identified in most vertebrates including humans, mice, and zebrafish.
Several secreted BMP regulators with Chordin-like CR domains also have been identified. Kielin/Chordin-like protein (Kcp) with 18 Chordin-like CR domains, one thrombospondin domain (Tsp), and one von Willebrand factor D (vWF-D) domain enhances BMP signaling (13) . Crossveinless-2 with five Chordin-like CR domains and one vWF-D domain is a BMP agonist/antagonist (14, 15) . Connectivetissue growth factor, which has four structural domains including the Chordin-like CR domain, insulin-like growth factor domain, Tsp domain, and C-terminal knot, modulates BMP signaling and TGFb signaling negatively and positively, respectively (16) . However, these regulators are functionally and structurally distinct from secreted BMP antagonists, Chordin, Chrdl1, Chrdl2, Brorin, and Brorin-like, with only Chordin-like CR domains as structural domains.
Several excellent reviews on BMPs and secreted BMP regulators have been published (2-4, 16, 17) . In this article, we briefly review secreted BMP antagonists with only Chordin-like CR domains as structural domains, focusing on their possible evolutionary history, physiological roles in mice and zebrafish, and pathophysiological roles in humans.
Identification of Chordin
Chordin was originally identified as a novel dorsalizing factor gene, the Spemann organizer gene, activated by organizer-specific homeobox genes in Xenopus (5). Chordin is a secreted BMP antagonist that binds to BMP2, BMP4, and BMP7 but not to TGFb1 and Activin (18) . Chordin is the vertebrate ortholog of Short gastrulation (Sog) in Drosophila (19, 20) , and has been identified in most vertebrates including humans, mice, and zebrafish (21) . Chordin is a secreted protein that contains four highly conserved CR domains of 60 to 80 amino acids ( Figure 1A ).
Cysteine-rich domains in Chordin
As described above, secreted BMP antagonists can be classified into five groups; the DAN family, Noggin, Twsg1, Follistatin, and Chordin, based on characteristic CR domains (2) (3) (4) (5) . The DAN family includes Gremlin, Cerberus, Coco, DAN, SOST, and Ectodin/USAG-1/Wise with eight-membered conserved CR domains. Twsg1 has a nine-membered CR domain. Follistatin has a CR domain containing 36 cysteine residues. By contrast, Chordin and Noggin have different types of 10-membered CR domains (3). Chordin is therefore a unique BMP antagonist.
The CR domain in Chordin has a CXXCXC motif in the middle and a CCXXC motif at the carboxyl terminus ('X'; any amino acid) (3). This domain is also known as the von Willebrand factor type C domain (22) . Chordin-like CR domains have been identified in approximately 200 extracellular proteins. Procollagen IIA, also has a Chordin-like CR domain, of which the disulfide bond pattern is unambiguously assigned as C 1 -C 4 , C 2 -C 8 , C 3 -C 5 , C 6 -C 9 , and C 7 -C 10 (7). The CR domain could be divided into two sub-domains, the N-terminal and C-terminal sub-domains. The N-terminal sub-domain is similar to the fibronectin type 1 domain. However, no structural matches could be identified for the Cterminal sub-domain (7) .
Identification of Chrdl1, Chrdl2, Brorin, and Brorin-like A gene encoding a secreted protein was identified in mouse bone stromal cells by signal sequence trap screening. The protein, Chrdl1, is significantly similar to Chordin, but has only three Chordin-like CR domains not four ( Figure 1A ). Chrdl1 transcripts have long and short forms generated by alternative splicing. However, although the two forms differ in the lengths of their C-terminal regions, they have the same three CR domains. Chrdl1 is a Bmp antagonist that binds to BMP4 and BMP6 but not BMP5 and Activin. In contrast to Chordin, Chrdl1 weakly interacts with TGFb1 and TGFb2 (9) . Neuralin 1 was identified in the human genome by a homology-based search (23) . Ventroptin was identified as a gene expressed with a double-gradient pattern in the chick retina (24) . Neurogenesin 1 was identified in rat hippocampal astrocytes by a homology-based polymerase chain reaction (25) . Neuralin 1, Ventroptin, and Neurogenesin 1 are synonyms of Chrdl1. Chrdl2 was also identified in mouse placenta by signal sequence trap screening. Chrdl2 is a secreted protein that is structurally homologous to Chrdl1 and Chordin (41% and 33% amino acid identity, respectively). Chrdl2 also has three Chordin-like CR domains ( Figure 1A ). Chrdl2 is a BMP antagonist that binds to BMP2, BMP4, BMP5, BMP6, and BMP7 but not to TGFb1, TGFb, and Activin (10) .
Brorin was identified in mouse embryos by searching for cDNAs encoding unknown secreted proteins. Although not significantly homologous to Chordin, Chrdl1, and Chrdl2, Brorin has two only Chordin-like CR domains ( Figure 1A ). The second CR domain (CR2) has the conserved CXXCXC and CCXXC motifs observed in Chordin and Chrdl1, and Chrdl2. By contrast, the first CR domain (CR1) has a unique CXCXC and CCXXC motif slightly distinct from the conserved motifs. Brorin is a BMP antagonist that inhibits BMP2 and BMP6 in cultured preosteoblastic cells (11) . Brorin-like was also identified in mouse embryos by searching for cDNAs encoding unknown secreted proteins. Brorin-like is a secreted protein that is significantly similar (48.6% amino acid identity) to Brorin. It also has only two CR domains similar to those of Brorin ( Figure 1A ). Brorin-like is also a BMP antagonist that inhibits BMP2 and BMP6 in cultured preosteobalstic cells (12) . von Willebrand factor C domain containing 2 (Vwc2) and von Willebrand factor C domain containing protein 2-like (Vwc2l) (GenBank nucleotide sequence database, http://www.ncbi.nlm.nih.gov/nucleotide/) are synonyms of Brorin and Brorin-like, respectively.
Possible evolutionary history
The evolutionary lineage of metazoan organisms (metazoa) is shown in Figure 2 (26) . The fruit fly, Drosophila melanogaster, is a protostome. The ascidian, Ciona intestinalis, is a urochordate, the closest living relative of the vertebrates (27) . The zebrafish, Danio rerio, is a teleost. Humans and mice are tetrapods. The genomes of all these metazoa have been sequenced. Most gene expansions occurred in two major phases during metazoan evolution ( Figure 2 ). The first phase (Phase I) occurred in the metazoan lineage, after the divergence of protostomes and deuterostomes. In the first phase, gene duplications occurred. The second phase (Phase II) took place in the chordate lineage, during the early emergence of vertebrates. In the second phase, two genome duplication events occurred ( Figure 2 ) (26, 28, 29) .
Chordin, Chrdl1, Chrdl2, Brorin, and Brorin-like have been identified in most vertebrates ( Figure 2 ) (Ensemble, http://www.ensemble.org/). These results indicate that they are common genes in vertebrates. Sog is the Drosophila ortholog of the vertebrate Chordin (19, 20) . By contrast, no ortholog of Chrdl1 and Chrdl2 has been identified in Drosophila. However, Chrdl1 and Chrdl2 might be lost at later evolution stages, because extensive gene loss occurred in metazoan lineages (30) . The ortholog of Chordin has been The sequencing of the fruit fly, ascidian, zebrafish, mouse, and human genomes has been completed. Most gene expansions occurred in two major phases during metazoan evolution. The first phase (Phase 1) occurred in the metazoan lineage, after the divergence of protostomes and deuterostomes. In the first phase, gene duplications occurred. The second phase (Phase II) took place in the chordate lineage, during the early emergence of vertebrates. In the second phase, two genome duplication events occurred. An additional genome duplication event (Phase III) occurred shortly before the teleost radiation.
found in the C. intestinalis genome. Potential orthologs of Chrdl1 and Chrdl2 have also been found in the C. intestinalis genome (unpublished observation). These results indicate that ancestral genes of the vertebrate Chordin, Chrdl1, and Chrdl2 were generated in the early metazoan lineage ( Figure  2 ).
Human Chordin, Chrdl1, Chrdl2, Brorin, and Brorin-like are widespread in the genome ( Figure 1B) . The organization and location of the genes potentially suggest the evolutionary history of genes (31) . Although the conserved gene location (synteny) between Chrdl1 and Chrdl2 genes is not observed (data not shown), Chrdl1 and Chrdl2 genes have nearly the same exon-intron organization ( Figure 1A ) (10), indicating they were generated from a common ancestor by gene duplication at Phase I in the early metazoan lineage (Figure 2 ). By contrast, no ortholog of Brorin and Brorin-like has been identified in C. intestinalis and Drosophila genomes ( Figure  2 ) (unpublished observation). In addition, the conserved exon-intron organization and synteny between Brorin and Brorin-like are observed ( Figure 1A and C) (12) . These results indicate that Brorin and Brorin-like were potentially generated from an ancestral gene by a genome duplication event at Phase II in early vertebrate evolution (Figure 2) . However, to make the origin of the ancestral gene clear, other protostome and deuterostome genomes should be further examined.
Chordin, Chrdl2, Brorin, and Brorin-like have been identified in zebrafish (12, 32) , but Chrdl1 has not (Figure 2 ) (28). Chrdl1 has not been identified in other teleosts including fugu and stickleback either (unpublished observation). These results indicate that Chrdl1 might have been lost early during teleost evolution. Comparisons of mammalian and teleostean genes have shown that there are often two paralogs of the mammalian equivalent in teleosts. This suggests that there was an additional genome duplication event (Phase III) shortly before the teleost radiation (Figure 2) . This partial or whole genome duplication event was followed by rapid gene loss because gene duplications account for only approximately 20% of zebrafish genes (33) . However, no teleostspecific duplicate of these genes has been identified in teleosts including zebrafish, fugu, and stickleback (unpublished observation).
Mechanism of action
BMPs dimerize to form an active moiety. The active BMPs bind to specific type I and type II Ser/Thr kinase receptors at the cell surface, propagating their signals via the phosphorylation of Smads1/5/8 and other intracellular effectors. The type II receptor then forms a heterodimer with the type I receptor, and the constitutive kinase of the type II receptor activates the type I receptor (4). Chordin inhibits BMP signaling by binding to BMPs. The binding prevents BMPs from binding to their receptors. Twsg1 binds to both Chordin and BMP, facilitating the formation of a Chordin-BMPTwsg1 complex. The trimolecular complex prevents BMP from binding to its receptors (34) . The binding is reversible. Active BMPs are released from the complex by a metalloproteinase, Tolloid, which cleaves Chordin at two specific sites, after the first CR domain and between the third and fourth CR domains. Sizzled, a secreted protein, inhibits Tolloid. Sizzled acts as a negative feedback inhibitor of BMP signaling (34) . Ont1 (Olfml3, Olfactomedin-like3), a secreted protein of the Chordin pathway, contains two distinct domains, a coiled-coil domain and an olfactomedin domain. The coiled-coil domain binds to Tolloid/BMP and the olfactomedin domain binds to Chordin. Ont1 functions as an extracellular scaffold protein that brings Tolloid and Chordin together (34, 35) .
Chrdl1 and Chrdl2 inhibit BMP signaling by binding directly to BMPs (9, 10) . Although Brorin and Brorin-like also inhibit BMP signaling, it is unclear whether they bind to BMPs (11, 12). As described above, four CR domains in Chordin are essential for the regulation of the actions of Chordin. However, Chrdl1, Chrdl2, Brorin, and Brorin-like contain only two or three CR domains. Although their action mechanisms mostly remain unclear, they might be distinct from that of Chordin.
Physiological roles in mouse and zebrafish development
Chordin plays roles in dorsal-ventral patterning and neural induction in Xenopus embryos (36) . The mouse is widely used as a model for studying gene functions in vivo. Chordin, Chrdl1, Chrdl2, Brorin, and Brorin-like have been identified in mice. Chordin is first expressed in the anterior primitive streak and then in the node and the axial mesendoderm in mouse embryos, indicating that Chordin potentially plays a role in patterning in the early embryo (37) . During limb development in mouse embryos, Chordin is expressed only at the distal ends of the skeletal elements, indicating that Chordin might also play a role in endochondral ossification (38) . To examine the physiological roles of Chordin in mammals, Chordin knockout mice were generated ( Table 1) . The mice display a normal early development and neural induction but later defects in inner and outer ear development (37) . They also display an extensive array of malformations that encompass most features of DiGeorge syndrome in humans, indicating a role for Chordin in pharyngeal development (39) . In addition, their phenotype indicates a role in venous and arterial patterning (40) . Noggin has no structural similarity to Chordin (41) . However, double Chordin/Noggin knockout mice display defects in the development of the forebrain, eye, and facial structures, and exhibit a disrupted mesoderm development and left to right patterning. These results indicate that both Chordin and Noggin are required for the proper establishment of the three body axes in mouse embryos (37) .
The expression profile of Chrdl1 in mice is distinct from that of Chordin, although the two products have similar activities. Chrdl1 is first expressed in the neural plate at midgastrulation. Later on, Chrdl1 is expressed in discrete regions of the central nervous system and derivatives of the neural crest cells. During organogenesis, Chrdl1 is broadly expressed in many tissues including the dorsal root ganglia, the gut, condensing cartilages of the skeleton, and developing hair follicles (9, 23) . It is also expressed in the hippocampal astrocytes and dentate granule cells in the brain (25) . The expression profile of Chrdl1 indicates potential roles in various developmental processes. However, because Chrdl1 knockout mice have not been reported, its physiological roles remain unclear.
Although Chrdl2 is structurally most similar to Chrdl1, the expression profile of Chrdl2 differs from that of Chrdl1. Chrdl1 is restrictedly expressed in chondrocytes of developing joint cartilages and connective tissues in reproductive organs in mice. Chrdl2 is expressed in adult mesenchymal progenitor cells, and its expression decreases during chondrogenic differentiation (10) . The expression profile of Chrdl2 indicates potential roles in developmental processes including chondrogenesis. However, because Chrdl2 knockout mice have not been reported, the physiological roles of Chrdl2 also remain unclear.
Brorin is predominantly expressed in the developing diencephalon at early stages and in the developing neural tissues at later stages in mouse embryos. Although widely expressed in the brain, Brorin is mainly expressed in the diencephalon and medulla oblongata. The cellular distribution of Brorin expression indicates that Brorin is expressed in neurons but not in glial cells (11) . These results indicate potential roles in neural development and functions. Recently, Brorin knockout mice have been generated. However, the mice were viable and apparently normal (Table 1 ) (unpublished observation). The expression profile of Brorin-like is also similar to that of Brorin in mouse embryos and the adult brain (12) . Brorin-like knockout mice have also been generated. Again, the mice were viable and apparently normal (Table 1 ) (unpublished observation). Physiological roles of Brorin and Brorin-like in mice remain unclear.
The zebrafish is also widely used for studying gene functions in vivo. Chordin is initially expressed shortly after the midblastula transition and comes to be strongly expressed in the organizer region at early gastrulation stages in zebrafish. In addition, Chordin is also transiently expressed in the developing brain and in the paraxial mesoderm and ectoderm (42) . By screening for randomly induced zygotic mutations, dino mutant embryos were identified (Table 1 ). In the mutant embryos, the tail is enlarged at the expense of the head and the anterior region of the trunk. The phenotype suggests that dino is required for the establishment of dorsal fates in both the marginal and the animal zone of early gastrula embryos (43) . The dino phenotype is caused by a mutation in Chrodin (44) . The function of Chordin during gastrulation is important for the correct morphogenesis of the adult skeleton in zebrafish (45) .
Chrdl2 has been identified in zebrafish, but Chrdl1 has not. The absence of Chrdl1 suggests that Chrdl2 could serve the roles of both Chrdl1 and Chrdl2 (32) . Although Chrdl2 is maternally expressed, it is also expressed later in development with spatiotemporal patterns that differ from but overlap those of Chordin (32) . Loss-of-function experiments involving the injection of Morpholino antisense oligonucleotides have demonstrated that Chrdl2 serves as a BMP antagonist with functions that overlap those of Chordin in forming the dorsoventral axis (Table 1) (32) .
Brorin-like is strongly expressed in the zebrafish embryonic brain including several discrete regions in the forebrain, midbrain, and hindbrain. Its profile of neural tissue-specific expression in zebrafish embryos is essentially consistent with that in mouse embryos (12) . Loss-of-function experiments with Brorin-like Morpholino antisense oligonucleotides revealed morphological abnormalities in the zebrafish embryonic brain and eye. The formation of the telencephalic and tectal ventricles was apparently impaired. In addition, the formation of the constriction between the midbrain and hindbrain was also impaired (Table 1) (12) .
Brorin is also markedly expressed in the zebrafish embryonic brain. Its profile of neural tissue-specific expression is slightly different from that of Brorin-like (12) . Brorin knockdown embryos also show morphological abnormalities in the brain and eye (unpublished) ( Table 1) . However, the phenotype of these embryos is apparently severer than that of Brorin-like knockdown embryos. The formation of the telencephalic and tectal ventricles and constriction between the midbrain and hindbrain is also apparently impaired in Brorin-like knockdown embryos (unpublished observation). Because the phenotype of Brorin knockdown embryos is similar to, but distinct from, that of Brorin-like knockdown embryos, Brorin and Brorin-like potentially play roles, which are similar to but distinct from each other, in neural development.
Pathophysiological roles in humans
Holoprosencephaly (HPE) is the common malformation of the forebrain resulting from a failure of the left and right hemispheres to completely septate at the rostral end of the neural tube. Mouse mutants with reduced levels of Chordin and Noggin display mutant phenotypes remarkably analogous to the range of malformations seen in HPE. The study of Chordin and Noggin mutant mice will help us to understand the molecular, cellular, and genetic pathogenesis of HPE and associated malformations ( Table 2 ) (46) . Several loci for HPE have been mapped to specific chromosomal sites wOnline Mendelian Inheritance in Man (OMIM); http:// www.ncbi.nlm.nih.gov/omim/x. However, Chordin and Noggin are located at 3q27.1 and 17q22, different from any of these sites, indicating that they are not directly causative of HPE.
DiGeorge syndrome covers a spectrum of head and neck malformations. Chordin mutant mice display an extensive array of malformations that encompass most features of the syndrome. The Chordin mutation provides a mouse model for head and neck congenital malformations and suggests that Chordin/BMP signaling participates in the pathogenesis (Table 2 ) (39). However, the gene locus for DiGeorge syndrome has been mapped to 22q11.2 (OMIM), different from that of Chordin, 3q27.1, indicating that Chordin is not a direct cause of the syndrome.
Ovarian cancers mostly derive from the monolayer epithelium that covers the ovary. Chordin is underexpressed in epithelium ovary cancers and epithelial cancer cell lines. Chordin could participate in regulating BMP activity in the normal ovarian epithelium and its misexpression could lead to cancer incidence and/or progression (Table 2) (47) .
In normal human cartilage, Chordin is detected at low levels, mainly in the very superficial layers. In osteoarthritic cartilage, Chordin is detected at significantly higher levels in the very superficial layers. By contrast, Chordin expression is significantly downregulated in osteoarthritic chondrocytes by growth factors. The differential distribution and regulation of Chordin in normal and osteoarthritic cartilage and chondrocytes suggest an involvement of Chordin in the osteoarthritic process (Table 2) (48) .
Pericytes play a specialized role in regulating angiogenesis and vascular function by providing vascular stability and controlling endothelial cell proliferation. Disorders in pericyte function and pericyte-endothelial interaction have been observed in several disease states including tumor angiogenesis and diabetic microangiopathy. In ischemic retinal disease, hypoxia is a potent driver of retinal angiogenesis. Hypoxia induces the expression of Chrdl1 in human retinal pericytes (49) . BMP4 has been implicated in angiogenesis through a VEGF-dependent mechanism (50) . Chrdl1 expression by retinal pericytes in response to hypoxia could play an important role in regulating retinal angiogenesis through modulation of BMP4 actions on endothelial cells (49) .
Stimulation of the BMP pathway protects the kidney from acute and chronic injury. Chrdl1 is expressed in the ischemiasensitive S3 segment in humans. Chrdl1 specifically antagonizes BMP7, which is expressed in the neighboring distal nephron. Upon ischemia-induced degeneration of the S3 segment, Chrdl1 expression is decreased. Chrdl1 expression coincides with intense BMP signaling in tubules of the recovering kidney. These results indicate that Chrdl1 reduces BMP7 signaling in healthy proximal tubules, and the loss of this activity upon sloughing of injured epithelia promotes BMP7 signaling in repopulating, dedifferentiated epithelia (51).
Expert opinion and outlook
Disulfide bonds formed by pairs of cysteine residues in proteins are essential for the formation of unique functional motifs and protein folds. Two intrachain disulfide bonds formed by four cysteine residues represent a unique framework for the formation of a cystine ring. Chordin contains four highly conserved cysteine domains but not other functional domains. Chordin is a secreted BMP antagonist. Most secreted BMP antagonists including the DNA family, Follistatin, Noggin, and Twsg1 also contain CR domains. However, the CR domains in Chordin are unique.
Several secreted BMP antagonists, Chrdl1, Chrdl2, Brorin, and Brorin-like, have been identified. They also contain the Chordin-like CR domains but not other functional domains. Chordin, Chrdl1, Chrdl2, Brorin, and Brorin-like have been identified in most vertebrates. Chordin, Chordin-like 1, and Chordin-like 2 were generated early in the metazoan lineage. However, Brorin and Brorin-like were generated by a genome duplication event early during vertebrate evolution.
The action mechanism of Chordin has been extensively elucidated. Four CR domains appear to be essential for the regulation of its actions. However, Chrdl1, Chrdl2, Brorin, and Brorin-like contain only two or three cysteine-rich domains. Although their action mechanisms mostly remain unclear, they might be distinct from that of Chordin.
The mouse and zebrafish are widely used vertebrate models for studying gene functions in vivo. These BMP antagonist gene knockout/knockdown in mice and zebrafish indicate physiological roles. In addition, their aberrant expression and serum levels might result in disease, indicating pathophysiological roles in humans. Further analysis will promote our understanding of their roles in developmental and metabolic processes.
